US Patent Issued to AKESO BIOPHARMA on Oct. 21 for "Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,208, issued on Oct. 21, was assigned to AKESO BIOPHARMA INC. (Guangdong, China).

"Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses" was invented by Baiyong Li (Guangdong, China), Yu Xia (Guangdong, China), Zhongmin Wang (Guangdong, China), Peng Zhang (Guangdong, China) and Xinghua Pang (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the fields of tumor therapy and molecular immunology, and provides an anti-CTLA4 monoclonal antibody or antigen binding fragment thereof, a pharmaceutical composition thereof and use thereof. The monoclonal antibody of ...